Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Triantafyllos Doskas

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
The International Journal of Neuroscience|February 2, 2021
Neurocognitive impairment and social cognition in multiple sclerosisTriantafyllos Doskas, George D Vavougios, Panagiota Karampetsou, et al.
Neurology International|April 26, 2024
Neurocognitive Impairment and Social Cognition in Parkinson's Disease PatientsTriantafyllos Doskas, Konstantinos Vadikolias, Konstantinos Ntoskas, et al.
Rheumatology (Oxford, England)|January 6, 2021
Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohortDionysis Nikolopoulos, Dimitris Kitsos, Matilda Papathanasiou, et al.
Alzheimer'S Research & Therapy|February 28, 2023
Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trialBruno Dubois, Jesús López-Arrieta, Stanley Lipschitz, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 8, 2024
The mediating role of processing speed on the relationship between executive functions and social cognition in relapsing-remitting multiple sclerosis patientsTriantafyllos Doskas, Constantinos Kormas, Liberis Dekavallas, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
Explainable Machine Learning in the Prediction of DepressionChristina Mimikou, Christos Kokkotis, Dimitrios Tsiptsios, et al.
Advances in Therapy|June 21, 2017
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease PatientsRejko Krüger, Paul Lingor, Triantafyllos Doskas, et al.
Healthcare (Basel, Switzerland)|July 12, 2025
Beyond Physical Disability: The Social Cognition Challenges in Quality of Life Among Multiple Sclerosis PatientsTriantafyllos Doskas, Kanellos C Spiliopoulos, Constantinos Kormas, et al.
Brain Sciences|June 26, 2025
Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer's DiseaseTriantafyllos Doskas, George D Vavougios, Constantinos Kormas, et al.
Cell Metabolism|August 2, 2020
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in AutoimmunityThemis Alissafi, Lydia Kalafati, Maria Lazari, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
The International Journal of Neuroscience|February 2, 2021
Neurocognitive impairment and social cognition in multiple sclerosisTriantafyllos Doskas, George D Vavougios, Panagiota Karampetsou, et al.
Neurology International|April 26, 2024
Neurocognitive Impairment and Social Cognition in Parkinson's Disease PatientsTriantafyllos Doskas, Konstantinos Vadikolias, Konstantinos Ntoskas, et al.
Rheumatology (Oxford, England)|January 6, 2021
Demyelination with autoimmune features: a distinct clinical entity? Results from a longitudinal cohortDionysis Nikolopoulos, Dimitris Kitsos, Matilda Papathanasiou, et al.
Alzheimer'S Research & Therapy|February 28, 2023
Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trialBruno Dubois, Jesús López-Arrieta, Stanley Lipschitz, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|December 8, 2024
The mediating role of processing speed on the relationship between executive functions and social cognition in relapsing-remitting multiple sclerosis patientsTriantafyllos Doskas, Constantinos Kormas, Liberis Dekavallas, et al.
Diagnostics (Basel, Switzerland)|June 13, 2025
Explainable Machine Learning in the Prediction of DepressionChristina Mimikou, Christos Kokkotis, Dimitrios Tsiptsios, et al.
Advances in Therapy|June 21, 2017
An Observational Study of the Effect of Levodopa-Carbidopa Intestinal Gel on Activities of Daily Living and Quality of Life in Advanced Parkinson's Disease PatientsRejko Krüger, Paul Lingor, Triantafyllos Doskas, et al.
Healthcare (Basel, Switzerland)|July 12, 2025
Beyond Physical Disability: The Social Cognition Challenges in Quality of Life Among Multiple Sclerosis PatientsTriantafyllos Doskas, Kanellos C Spiliopoulos, Constantinos Kormas, et al.
Brain Sciences|June 26, 2025
Neurocognitive Impairment After COVID-19: Mechanisms, Phenotypes, and Links to Alzheimer's DiseaseTriantafyllos Doskas, George D Vavougios, Constantinos Kormas, et al.
Cell Metabolism|August 2, 2020
Mitochondrial Oxidative Damage Underlies Regulatory T Cell Defects in AutoimmunityThemis Alissafi, Lydia Kalafati, Maria Lazari, et al.
Pageof 3